Обявление за възложена поръчка на основание чл. 266а, ал. 5, т. 3 от Закона за лекарствените продукти в хуманната медицина, във вр. с чл. 1, ал. 1, т. 2, чл. 3, ал. 3, чл. 15в, ал. 1 и чл. 15б от Наредба № 10/17.11.2011 г. на Министерство на здравеопазването

University Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski" EAD awarded a contract to REIMEKS FARMA OOD on 30 April 2026 for the supply of Sodium oxybate (Xyrem, UCB Pharma S.A.) oral solution, 500 mg/ml, with a total contract value of 10,064.26 EUR. The procurement was conducted under pharmaceutical product regulations and the supplier is obligated to deliver upon receipt of authorization from the Drug Agency and written delivery request.